Skip to main content

Nutritional Deficiency

0
Pipeline Programs
4
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
3 programs
Biofortified MaizeN/A1 trial
Day 1: Maize Tortillas with 20% AmaranthN/A1 trial
Pearl milletN/A1 trial
Active Trials
NCT02208635Completed60Est. Dec 2015
NCT02208609Completed20Est. Dec 2015
NCT01783067Completed44Est. Jan 2012
Baxter International
1 program
Back Side of the MoonN/A1 trial
Active Trials
NCT03724045Completed50Est. Sep 2021
Baxter
BaxterCosta Rica - Cartago
1 program
Back Side of the MoonN/A
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Sugar PillN/A1 trial
Active Trials
NCT00833092Completed111Est. Dec 2008

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Baxter InternationalBack Side of the Moon
Colorado TherapeuticsBiofortified Maize
Colorado TherapeuticsDay 1: Maize Tortillas with 20% Amaranth
Colorado TherapeuticsPearl millet
Human BioSciencesSugar Pill

Clinical Trials (5)

Total enrollment: 285 patients across 5 trials

NCT03724045Baxter InternationalBack Side of the Moon

Back Side of the Moon: Nutritional Therapy

Start: Jan 2019Est. completion: Sep 202150 patients
N/ACompleted

Absorption of Zinc (Zn) From Zn-biofortified and Zn-fortified Maize in Young Zambian Children Between 24-36 Months

Start: Oct 2012Est. completion: Dec 201560 patients
N/ACompleted
NCT02208609Colorado TherapeuticsDay 1: Maize Tortillas with 20% Amaranth

Zinc Bioavailability From Amaranth-enriched Maize Tortillas

Start: Jan 2012Est. completion: Dec 201520 patients
N/ACompleted

Zinc and Iron Bioavailability From Biofortified Pearl Millet

Start: Feb 2011Est. completion: Jan 201244 patients
N/ACompleted

Magnesium Nutrition and Sleep Behavior in Older Adults

Start: Jan 2008Est. completion: Dec 2008111 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.